"Nov. 5, 2012 -- Counseling parents on the health risks of too much TV time for their toddlers doesn't seem to help break the TV habit.
Researchers thought that educating parents about the dangers of excess screen time, with suggestion"...
Oxandrin (oxandrolone) is indicated as adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in some patients who without definite pathophysiologic reasons fail to gain or to maintain normal weight, to offset the protein catabolism associated with prolonged administration of corticosteroids, and for the relief of the bone pain frequently accompanying osteoporosis (See DOSAGE AND ADMINISTRATION).
DOSAGE AND ADMINISTRATION
Therapy with anabolic steroids is adjunctive to and not a replacement for conventional therapy. The duration of therapy with Oxandrin (oxandrolone) will depend on the response of the patient and the possible appearance of adverse reactions. Therapy should be intermittent.
Adults: The response of individuals to anabolic steroids varies. The daily adult dosage is 2.5 mg to 20 mg given in 2 to 4 divided doses. The desired response may be achieved with as little as 2.5 mg or as much as 20 mg daily. A course of therapy of 2 to 4 weeks is usually adequate. This may be repeated intermittently as indicated.
Children: For children the total daily dosage of Oxandrin (oxandrolone) is ≤ 0.1 mg per kilogram body weight or ≤ 0.045 mg per pound of body weight. This may be repeated intermittently as indicated.
Geriatric Use: Recommended dose for geriatric patients is 5 mg bid.
Oxandrin (oxandrolone) 2.5 mg tablets are oval, white, and scored with BTG on one side and "11" on each side of the scoreline on the other side; bottles of 100 (NDC 54396-111-11).
Oxandrin (oxandrolone) 10 mg tablets are capsule shaped, white, with BTG on one side and "10" on the other side; bottles of 60 (NDC 54396-110-60).
Manufactured for: Savient Pharmaceuticals, Inc. Manufactured by: DSM Pharmaceuticals, Inc. Greenville, NC 27834. Pfizer Co. New York, NY 10017. Address medical inquires to: Savient Pharmaceuticals, Inc. One Tower Center. Fourteenth Floor East Brunswick, NJ 08816. 866-692-6374. Issued January 2006.
Last reviewed on RxList: 3/31/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Oxandrin Information
Oxandrin - User Reviews
Oxandrin User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Parenting and Pregnancy
Get tips for baby and you.